IL33 and inflammatory bowel disease: Since IL-33 has been localised to enterocytes and the lamina propria of IBD patients and healthy controls2, 4, we hypothesised that IL-33 might directly modulate the differentiation of enterocytes and macrophages into goblet cells and M2 macrophages, respectively, but not through modulation of Treg and Th2.